Raloxifene, a medication used to prevent bone loss in postmenopausal women, was able to reduce fibrosis, or scarring, in cell…
Articles by Lindsey Shapiro, PhD
The investigational oral therapy APT-101 was well tolerated and reduced fibrosis, or scarring, in a mouse model of systemic…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to efzofitimod (ATYR1923) to treat interstitial lung disease…
Several clinical characteristics in people with systemic sclerosis (SSc) — specifically, being male, older age, diffuse SSc forms, and…
New data from patient samples and a mouse model provide support for the further development of Chemomab Therapeutics‘ lead candidate,…
Nailfold videocapillaroscopy (NVC), a technique to detect small changes in circulation, may be a promising biomarker of likely severe organ…
Low muscle mass is associated with gastrointestinal (GI) bloating in patients with systemic sclerosis (SSc), a recent study revealed.
Shorter telomeres — the protective ends on chromosomes and a marker of aging — were observed in people with…
Levels of the protein, galectin-3, are associated with heart involvement in people with systemic sclerosis (SSc), according to a…
The U.S. Food and Drug Administration (FDA) has approved a clinical trial to determine the safety and efficacy of…